Zoventa is indicated for the treatment of individuals with mild-to-moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below.
Acute Bacterial Exacerbations of Chronic Bronchitis
: Due to Haemophilus influenzae (including β-lactamase producing strains), Moraxella catarrhalis (including (β-lactamase producing strains), or Streptococcus pneumoniae (penicillin-susceptible strains only).
... Read more
Zoventa is indicated for the treatment of individuals with mild-to-moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below.
Acute Bacterial Exacerbations of Chronic Bronchitis
: Due to Haemophilus influenzae (including β-lactamase producing strains), Moraxella catarrhalis (including (β-lactamase producing strains), or Streptococcus pneumoniae (penicillin-susceptible strains only).
Acute Bacterial Otitis Media
: Due to Haemophilus influenzae (including β-lactamase producing strains), Moraxella catarrhalis (including β-lactamase producing strains) or Streptococcus pyogenes.
Pharyngitis and Tonsillitis
: Due to Streptococcus pyogenes.
: >6 months: 9 mg/kg/day (maximum 400 mg) every 24 hours for 10 days
: >6 months: 9 mg/kg/day (maximum 400 mg) every 24 hours for 10 days
: >6 months: 9 mg/kg/day (maximum 400 mg) every 24 hours for 10 days
Ceftibuten is the dihydrate salt of Ceftibuten, is a semi-synthetic Cephalosporin antibiotic for oral administration. Ceftibuten exerts its bactericidal action by binding to essential target proteins of the bacterial cell wall. This binding leads to inhibition of cell-wall synthesis.
Nausea, headache, diarrhea, dyspepsia, dizziness, abdominal pain, vomiting.
Ceftibuten is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.
As with other broad-spectrum antibiotics, prolonged treatment may result in the possible emergence and overgrowth of resistant organisms. Careful observation of the patient is essential. The dose of Zoventa may require adjustment in patients with varying degrees of renal insufficiency. Zoventa should be prescribed with caution to individuals with a history of gastrointestinal disease, particularly colitis.
Hepatic Impairment: Dose adjustment is not necessary.
Pregnancy Category B. There are no controlled data on the use of Ceftibuten in pregnant women. Ceftibuten should be used in pregnancy only when the benefit clearly outweighs the risk. It is not known whether Ceftibuten (recommended dosage) is excreted in human milk. Because many drugs are excreted in human milk, caution should be excercised when Ceftibuten is administered to nursing women.
Theophylline & Antacid do not alter the pharmacokinetic profile of Zoventa. Ranitidine increases the Cmax & AUC of Zoventa.
Store below 25°C, protected from light and moisture. For Suspension: After reconstitution, the suspension may be used for 14 days while stored at 2° to 8°C. Keep out of reach of children.
Always consult a registered physician before taking any medicine. Prices shown are MRP and may vary by pharmacy.